Patient Information:
- Name: Mr. Liu
- Diagnosis: Type II Diabetes Mellitus
- Date of Birth (D.O.B): August 1, 1966
- Gender: Male
- Country: China
Treatment: Cellular Immune Therapy for Type II Diabetes combined with Nerve Growth Factor Treatment, Physical Therapy, Traditional Chinese Medicine (TCM), and Metabolic Control Management at Beijing Puhua International Hospital (BPIH)
Medical History:
Mr. Liu was admitted to BPIH due to Type II Diabetes of ten years duration.
Medical Condition before Cellular Immune Therapy for Type II Diabetes:
- Symptoms:
- Abnormal thirst
- Nocturia
- Intermittent blurred vision
- Medications:
- Metformin
- Phenformin
- Insulin injections
- Laboratory Results:
- HbA1c: 12.2%
- Fasting Blood Glucose (FBG): 14.0 mmol/L (252 mg/dL)
- Postprandial Blood Glucose (PBG): 23.6 mmol/L (425 mg/dL)
Cellular Immune Therapy for Type II Diabetes:
- Medical protocols applied:
- Cellular immune therapy to repair injured pancreatic islet cells
- Metabolic control management
- Traditional Chinese medicine (TCM)
- Rehabilitation therapy
Physical Condition after Cellular Immune Therapy for Type II Diabetes (30-day follow-up):
- Improved laboratory results:
- HbA1c: 8.6%
- FBG: 9.6 mmol/L (173 mg/dL) – a decrease of 4.4 mmol/L (79 mg/dL)
- PBG: 14.2 mmol/L (256 mg/dL) – a decrease of 9.4 mmol/L (169 mg/dL)
- Insulin dosage reduced by 50%
- Improved sleep quality
- Significant alleviation of symptoms:
- Thirst
- Nocturia
- Blurred vision
